N-(2-Bromophenyl)-2,2,2-trifluoroacetamide

Catalog No. :
ACGBRF184
CAS No. :
2727-71-1
Molecular Formula :
C8H5BrF3NO
Molecular Weight :
268.03

IUPAC Name:N-(2-bromophenyl)-2,2,2-trifluoroacetamide

N-(2-Bromophenyl)-2,2,2-trifluoroacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$67.00Login to see priceInquiryInquiry
250mg97%$86.00Login to see priceInquiryInquiry
1g97%$213.00Login to see priceInquiryInquiry
5g97%$581.00Login to see priceInquiryInquiry
10g97%$855.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Bromophenyl)-2,2,2-trifluoroacetamide
IUPAC NameN-(2-bromophenyl)-2,2,2-trifluoroacetamide
MDL No.MFCD00595489
Molecular FormulaC8H5BrF3NO
Molecular Weight268.03
SMILESO=C(NC1=CC=CC=C1Br)C(F)(F)F
InChI KeyYAIXIJZAVUCEAC-UHFFFAOYSA-N
SynonymAcetaMide, N-(2-broMophenyl)-2,2,2-trifluoro-;N-(2-BROMOPHENYL)-2,2,2-TRIFLUOROACETAMIDE;N-(2-bromo-4-isopropylphenyl)-2,2,2-trifluoroacetamide
CAS No.2727-71-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGBRF184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCGWL165 route compound structure diagram
    ACCGWL16594718-79-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGBRF184 route product structure diagram
    ACGBRF1842727-71-1
Inquiry

2. ACGBRF184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIKGZ463 route compound structure diagram
    ACIKGZ463404-24-0 In Stock
  4. Then
  5. ACGBRF184 route product structure diagram
    ACGBRF1842727-71-1
Inquiry

Comments (0)